Financial Results for Q2 FY27

The Board approved the unaudited financial results for the quarter ended June 30, 2026:

  • Revenue from Operations: ₹187.18 crore (compared to ₹193.08 crore in Q1 FY26 and ₹176.00 crore in Q2 FY25)
  • Other Income: ₹0.85 crore
  • Total Revenue: ₹188.03 crore
  • Total Expenses: ₹164.27 crore
  • Profit Before Tax: ₹23.75 crore
  • Tax Expense: ₹6.91 crore (Current Tax: ₹5.65 crore, Deferred Tax: ₹1.25 crore)
  • Net Profit: ₹16.85 crore
  • Basic and Diluted EPS: ₹8.43
  • Paid-up Equity Share Capital: ₹10.60 crore (2,12,08,918 equity shares of ₹5 each)

The results were reviewed by the Audit Committee and subjected to limited review by statutory auditors Singhi & Co.

Annual General Meeting

The Board approved convening the 52nd Annual General Meeting on Wednesday, September 23, 2026, at 12:30 PM through Video Conferencing/Audio-Visual Means.

Statutory Auditor Appointment

Based on Audit Committee recommendation, the Board recommended appointment of M/s. Ramasamy Koteswara Rao and Co LLP, Chartered Accountants (ICAI Firm Registration No. 010396S/S200084) as Statutory Auditors for a 5-year term from conclusion of 52nd AGM (2026) till conclusion of 57th AGM (2031), subject to shareholder approval.

Additional Notes from Financial Results

  • The company operates in a single segment: Chemicals in India
  • Final dividend of ₹4.50 per equity share (face value ₹5) recommended for FY26 on May 6, 2026, subject to shareholder approval
  • Board approved setting up of 20,000 MTPA downstream fluorinated product plant at estimated cost of ₹495 crore on January 9, 2026, currently under implementation with estimated commissioning in 12 months
  • Successfully completed QIP raising ₹249.99 crore through allotment of 12,58,918 equity shares at ₹1,985.83 per share (including premium of ₹1,980.83) on June 25, 2026
  • QIP resulted in 6.31% dilution, increasing paid-up capital to ₹10.60 crore
  • QIP proceeds were held in Escrow Account and Fixed Deposits as of June 30, 2026, pending utilization
  • Board approved sub-division of equity shares from ₹10 to ₹5 face value effective March 9, 2026
  • Board approved raising up to ₹99.41 crore via private placement on July 6, 2026, subject to shareholder approval at EGM on July 30, 2026
  • All comparative EPS figures restated for share sub-division

Meeting Details

The Board meeting commenced at 1:15 PM and concluded at 8:15 PM on July 24, 2026.

Auditor Review Report

Singhi & Co. issued a limited review report stating nothing came to their attention suggesting the financial results contain material misstatements or fail to comply with disclosure requirements under Regulation 33 of SEBI LODR Regulations.